| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
MDX/MEDIREX SYSTEMS Inc. is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Spinal Kinetics is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Sunnyvale, CA. To find more information about Spinal Kinetics, please visit www.spinalkinetics.com
Long Island Consultation Center is a Rego Park, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Doheny Eye Institute is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Doheny Eye Institute is based in Los Angeles, CA. You can find more information on Doheny Eye Institute at www.doheny.org